Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies

The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

pharmacology
Vaccines Without Vials, Fridges, or Needles
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Amy Schleunes | Apr 7, 2020
Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Ruth Williams | Dec 11, 2019
A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.
Cancer Drugs in Development May Be Targeting Wrong Proteins
Cancer Drugs in Development May Be Targeting Wrong Proteins
Shawna Williams | Sep 12, 2019
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Image of the Day: Right on Target
Image of the Day: Right on Target
Nicoletta Lanese | Jul 23, 2019
An injectable biomaterial calls cancer drugs to tumor sites in mice.
How the Brain Changes on Ketamine: A Live Animal Study
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Researchers Getting Smarter About Pairing Cancer Treatments
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Mar 31, 2018
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
Infographic: Cancer Drug Pairings
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.